Keyphrases
Ophthalmology Residents
100%
United States
43%
Ophthalmology Residency
37%
Residency Program
36%
Intractable Diplopia
33%
Diplopia
33%
Professionalism
33%
Gender Differences
33%
Healthy Individuals
33%
Desaturation
33%
Dry Eye
33%
Randomized Trial
33%
Nutritional Supplementation
33%
Female Resident
33%
Continuity Clinic
33%
Procedural Volume
33%
Fibrinogen
33%
Human Platelet Lysate
33%
Fovea
33%
Graft-versus-host Disease (GvHD)
33%
Age-related Macular Degeneration
33%
Senior Residents
33%
Outpatient Clinic
33%
Toxic Keratopathy
33%
Congenital Esotropia
33%
Clinical Characterization
33%
Medical Students
33%
Early Adulthood
33%
Mental Illness
33%
Antibody-drug Conjugate
33%
Keratopathy
33%
Histological Characterization
33%
ABT-414
33%
Belantamab Mafodotin
33%
Microcysts
33%
Yoga
33%
Uveitis-glaucoma-hyphema Syndrome
33%
Resident Performance
33%
COVID-19 Pandemic
33%
Viral Conjunctivitis
33%
Ophthalmology Clinic
33%
Lens Capsule
33%
Lenticular
33%
Post-traumatic
33%
Cataract Surgery
31%
Right Eye
27%
Ophthalmology
27%
Intraocular Lens
27%
Cataract Operation
26%
Resident Perceptions
22%
Medicine and Dentistry
Ophthalmology
100%
Cataract Surgery
44%
Medical Student
38%
Exotropia
38%
Glaucoma
33%
Hyphema
33%
Bullous Keratopathy
33%
Yoga
33%
Uveitis
33%
Diplopia
33%
Platelet Lysate
33%
Fatty Acid Desaturation
33%
Prevalence
33%
Chronic Graft Versus Host Disease
33%
Dry Eye
33%
Antibody-Drug Conjugate
33%
Depatuxizumab Mafodotin
33%
Sex Difference
33%
Congenital Strabismus
33%
Fibrinogen
33%
Fovea Centralis
33%
Visual Impairment
33%
Visual Acuity
33%
Eye Synechia
33%
Injury
33%
Capsule of Lens
33%
Surgery
33%
Viral Conjunctivitis
33%
COVID-19
33%
Intraocular Lens
22%
Photophobia
21%
Eye Discomfort
19%
Contact Lens
18%
Allergic Conjunctivitis
18%
Prone Position
16%
Supine Position
16%
Iris
16%
Eye Pain
16%
Body Position
16%
Ultrasound Biomicroscopy
16%
Intraocular Lens Explantation
16%
Iridocyclitis
16%
Vitrectomy
16%
Pseudoexfoliation Syndrome
16%
Intraocular Pressure
16%
Emergency Department
14%
Conjunctivitis
14%
Ocular Surface Disease Index
14%
Programmed Cell Death
13%
Clinical Trial
11%
